Kevin John 🧪🧩
@Kev_in_Science
Followers
284
Following
4K
Statuses
1K
Microbiologist 👨🏾🔬🇸🇬 Researching Down Under 🇦🇺 Mucosal Polyclonal 🧩 Covid Pundit 😷 Semen Demon 😈 Post Doc @AmyWChung lab @TheDohertyInst
Melbourne, Victoria
Joined May 2020
How do #mucosal antibodies respond after #vaccination or #covid breakthrough infection? 🤔 Do previous exposures shape future #humoral responses? Our work is finally out as twin publications in @JCI_insight and @ImmunolCellBiol Short🧵to follow 😉
New research shows mucosal surfaces in eyes, nose, mouth and throat are crucial to the first line of defence against upper respiratory infections, like #COVID19. Published in @JCI_insight @ImmunolCellBiol
@UniMelbMDHS @TheRMH @Kev_in_Science
1
6
21
RT @jbloom_lab: In new study, we find dramatic differences in specificities of serum neutralizing antibodies in infants w single infection…
0
110
0
RT @njmoreland: Following relaxation of #COVID19 restrictions surges in infections from respiratory pathogens like RSV and #StrepA have bee…
0
3
0
RT @SolidEvidence: Do you think you've had long-term GI problems since having Covid? We are performing a study examining the characterist…
0
379
0
RT @KimLJacobson: It's great to see this out today! A tour de de force by @MasatoOgishi Koji Kitaoka, @casanova_lab, @Tangye_Lab + others…
0
2
0
RT @LabTaia: Out today in @ImmunityCP! We define how sialylation of IgG Fc domains regulates NF-κB-driven responses in the lungs. https:…
0
15
0
RT @StuartTurville: I've covered most of this when our pre-print was up here: The final work is now published at h…
0
14
0
RT @jianfcpku: Excited to share our work about the evolving humoral immunity against SARS-CoV-2 XBB to JN.1 shift, released on Nature today…
0
45
0
RT @yunlong_cao: Our work on the evolving immunity against SARS-CoV-2 XBB and JN.1 is now out @Nature! Besides supporting the JN.1/KP.2 vac…
0
91
0
RT @TheDohertyInst: We're delighted to partner with @ASTARsg Infectious Diseases Labs to address the growing threat of infectious diseases…
0
1
0
RT @florian_krammer: "Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS…
0
43
0
RT @biorxiv_immuno: Enhanced immune evasion of SARS-CoV-2 KP.3.1.1 and XEC through NTD glycosylation #biorxiv_immu…
0
13
0
RT @LokShee: Postdoctoral fellowship in Singapore for applicants who are citizens from South East Asia countries.
0
7
0
RT @K_RenfreeShort: People in Brisbane and Melbourne we need your help! Please join our study to develop a much needed diagnostic test for…
0
101
0
RT @fossum_even: We analyzed antibodies against influenza A viruses in sera from 2019, 2021, 2022 and 2023 to evaluate the impact of the co…
0
7
0
RT @sciam: Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm
0
232
0
RT @LMackayLab: 1/ 🚨 Hot off the press! 🚨Our new paper, led by @ObersAndreas & @maxevrard, is now live in @ImmunityCP! 🧬 Curious how CD8+ t…
0
56
0